50 Chapter 2 102. Naito, H., Melnychenko, I., Didie, M., Schneiderbanger, K., Schubert, P., Rosenkranz, S., Eschenhagen, T. and Zimmermann, W. H. (2006). Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation 114, I72-I78. 103. Olivetti, G., Abbi, R., Quaini, F., Kajstura, J., Cheng, W., Nitahara, J. A., Quaini, E., Di Loreto, C., Beltrami, C. A., Krajewski, S. et al. (1997). Apoptosis in the failing human heart. N Engl. J. Med. 336, 1131-1141. 104. Olson, E. N. (2006). Gene regulatory networks in the evolution and development of the heart. Science 313, 1922-1927. 105. Osafune, K., Caron, L., Borowiak, M., Martinez, R. J., Fitz-Gerald, C. S., Sato, Y., Cowan, C. A., Chien, K. R. and Melton, D. A. (2008). Marked differences in differentiation propensity among human embryonic stem cell lines. Nat. Biotechnol. 106. Ottaviani, D., Ter Huurne, M., Elliott, D. A., Bellin, M. and Mummery, C. L. (2023). Maturing differentiated human pluripotent stem cells in vitro: methods and challenges. Development 150, dev201103. 107. Paige, S. L., Osugi, T., Afanasiev, O. K., Pabon, L., Reinecke, H. and Murry, C. E. (2010). Endogenous Wnt/β-catenin signaling is required for cardiac differentiation in human embryonic stem cells. PLoS One 5, e11134. 108. Paige, S. L., Plonowska, K., Xu, A. and Wu, S. M. (2015). Molecular regulation of cardiomyocyte differentiation. Circ. Res. 116, 341-353. 109. Parker, T. G., Packer, S. E. and Schneider, M. D. (1990). Peptide growth factors can provoke ‘fetal’ contractile protein gene expression in rat cardiac myocytes. J. Clin. Invest. 85, 507-514. 110. Piccolo, S., Agius, E., Leyns, L., Bhattacharyya, S., Grunz, H., Bouwmeester, T. and De Robertis, E. M. (1999). The head inducer cerberus is a multifunctional antagonist of nodal, BMP and Wnt signals. Nature 397, 707-710. 111. Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., Gonzalez-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A. et al. (2016). 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the ESC. Developed with the Special Contribution of the Heart Failure Association (HFA) of the ESC. Eur. J. Heart Fail 18, 891. 112. Porrello, E. R., Mahmoud, A. I., Simpson, E., Hill, J. A., Richardson, J. A., Olson, E. N. and Sadek, H. A. (2011). Transient regenerative potential of the neonatal mouse heart. Science 331, 1078-1080. 113. Ptaszek, L. M., Mansour, M., Ruskin, J. N. and Chien, K. R. (2012). Towards regenerative therapy for cardiac disease. Lancet 379, 933-942. 114. Qyang, Y., Martin-Puig, S., Chiravuri, M., Chen, S., Xu, H., Bu, L., Jiang, X., Lin, L., Granger, A., Moretti, A. et al. (2007). The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/β-Catenin pathway. Cell Stem Cell 1, 165-179. 115. Rochais, F., Mesbah, K. and Kelly, R. G. (2009). Signaling pathways controlling second heart field development. Circ. Res. 104, 933-942. 116. Rungarunlert, S., Techakumphu, M., Pirity, M. K. and Dinnyes, A. (2009). Embryoid body formation from embryonic and induced pluripotent stem cells: benefits of bioreactors. World J. Stem Cells 1, 11-21. 117. Saga, Y., Pulkki, K., Kallajoki, M., Henriksen, K., Parvinen, M. and Voipio-Pulkki, L.-M. (1999). MesP1 is expressed in the heart precursor cells and required for the formation of a single heart tube. Development 126, 3437-3447. 118. Saraste, A., Pulkki, K., Kallajoki, M., Henriksen, K., Parvinen, M. and Voipio-Pulkki, L.-M. (1997). Apoptosis in human acute myocardial infarction. Circulation 95, 320-323. 119. Schade, D., Drowley, L., Wang, Q. D., Plowright, A. T. and Greber, B. (2022). Phenotypic screen identifies FOXO inhibitor to counteract maturation and promote expansion of human iPS cell-derived cardiomyocytes. Bioorg. Med. Chem. 65. 120. Schneider, V. A. and Mercola, M. (2001). Wnt antagonism initiates cardiogenesis in Xenopus laevis. Genes Dev. 15. 121. Schulte-Merker, S. and Smith, J. C. (1995). Mesoderm formation in response to brachyury requires FGF signalling. Curr. Biol. 5, 62-67. 122. Sedmera, D. and Thompson, R. P. (2011). Myocyte proliferation in the developing heart. Dev. Dyn. 240, 1322-1334. 123. Sharma, A., Mckeithan, W. L., Serrano, R., Kitani, T., Burridge, P. W., Del Álamo, J. C., Mercola, M. and Wu, J. C. (2018a). Use of human induced pluripotent stem cell-derived cardiomyocytes to assess drug cardiotoxicity. Nat. Protoc.
RkJQdWJsaXNoZXIy MTk4NDMw